Candesartan Cilexetil Tablets, 16 mg, 30 Tablets (5 x 6) blister pack, Rx, Distributed by: Americ...
FDA Drug Recall #D-0660-2016 — Class III — January 26, 2016
Recall Summary
| Recall Number | D-0660-2016 |
| Classification | Class III — Low risk |
| Date Initiated | January 26, 2016 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Amerisource Health Services |
| Location | Columbus, OH |
| Product Type | Drugs |
| Quantity | 716 cartons |
Product Description
Candesartan Cilexetil Tablets, 16 mg, 30 Tablets (5 x 6) blister pack, Rx, Distributed by: American Health Packaging Columbus, Ohio 43217, NDC 68084-877-25(carton), NDC 68084-877-95(individual dose)
Reason for Recall
Failed Impurities/Degradation Specifications; 9 month stability (manufacturer)
Distribution Pattern
Nationwide
Lot / Code Information
Lot # 153855, exp 01/2017
Other Recalls from Amerisource Health Services
| Recall # | Classification | Product | Date |
|---|---|---|---|
| D-0091-2018 | Class II | Paroxetine Tablets, USP, 30mg, 100 tablets (10 ... | Oct 24, 2017 |
| D-0074-2018 | Class III | Enalapril Maleate Tablets, USP, 5 mg, 100 Table... | Aug 29, 2017 |
| D-0490-2017 | Class II | CycloSPORINE Capsules, USP, 100 mg, 30 count (5... | Feb 8, 2017 |
| D-0520-2017 | Class II | GlipiZIDE Extended-release tablets, 2.5 mg, 30-... | Feb 3, 2017 |
| D-0137-2017 | Class III | Bupropion Hydrochloride Extended-Release Tablet... | Oct 27, 2016 |
Frequently Asked Questions
Nitrosamines are probable human carcinogens — they can increase cancer risk with long-term exposure above certain thresholds, but they do not cause immediate harm from taking a single dose. The FDA calculates an acceptable daily intake (ADI) for each nitrosamine compound, and recalls are triggered when levels exceed this threshold. If you have been taking a recalled product, the FDA generally advises against abruptly stopping your medication (especially for critical conditions like blood pressure or diabetes) until you consult your doctor. The incremental cancer risk from short-term exposure is very small.
Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.
Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.
What Should You Do?
Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.